AzTrials
AzTrials

GaitNCT07085364

Attentional Focus Training on Visuomotor Control in Older Adults

A study testing Attentional focus in people with Gait and Attention, run by The Hong Kong Polytechnic University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This study will be a pilot randomized controlled trial, to investigate the effectiveness of an external focus training on visuomotor performance while comparing with an active control group. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Gait, Attention, Older Adults
What is being tested?
Attentional focus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
No sites listed yet
Study dates
1 Aug 2025to 31 May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • aged 65 or above
  • able to walk independently indoor for at least 40 metres
  • static visual acuity score 20/40 or above
  • scoring 22/30 or above in the Montreal Cognitive Assessment Hong Kong version
  • without any history of untreated major neurological, vestibular or musculoskeletal deficits (e.g., stroke or Parkinson's disease)
  • without any unstable medical condition that can compromise safety during the experiment
  • scoring less than 24/28 in the Tinetti Balance Assessment Tool or scoring 50/56 or below in the Berg Balance Scale

Who cannot join

  • none

About this study

This study will be a pilot randomized controlled trial, to investigate the effectiveness of an external focus training on visuomotor performance while comparing with an active control group.

Read the detailed description

All eligible participants will be randomly divided into two groups: external focus gait training group (EXT) and active control group (CON). All participants will complete two assessment sessions: at baseline (T0) and immediately following the completion of all training sessions (T1). A total of twelve training sessions (about 45 minutes per session), held twice a week for six weeks, would be provided to participants in both training groups.

Being tested
Attentional focus, Control
Keywords
attentional focus, gait, visual search, older adults

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Attentional focusBehavioural

    Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. Participants will be instructed to look at and step on specific markers/labels that will be attached along the walking paths.

  • ControlBehavioural

    Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. No markers/labels will be attached and no relevant instructions will be provided apart from the general instruction.

Study groups in NCT07085364
Study groupRoleWhat they receive
EXTExperimentalExternal focus manipulation
Receives: Behavioral: Attentional focus
CONActive comparatorTraditional manipulation
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait stability - variability of stride time

    measured by a 3-D motion capture system; stride time is defined as the interval between two consecutive heel strikes of the same foot; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  2. Gait stability - variability of stride length

    measured by a 3-D motion capture system; stride length is defined as anterior-posterior (A-P) distance between two consecutive heel strike positions of the same foot; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  3. Gait stability - variability of step width

    measured by a 3-D motion capture system; step width is defined as medial-lateral (M-L) distance between two consecutive heel strike positions of the opposite feet; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  4. Visual search behaviours - location of fixation

    measured by a wireless eye tracker; recorded the location that the gaze is fixated on

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  5. Visual search behaviours - the number of fixation

    measured by a wireless eye tracker; recorded the number of times the gaze is fixated on each area of interest

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  6. Visual search behaviours - fixation duration

    measured by a wireless eye tracker; recorded the duration that the gaze is fixated on each area of interest

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

Secondary outcomes (5)
  1. Functional balance and gait

    measured by the Tinetti Balance Assessment Tool; min: 0; max: 28; higher scores reflect better functional balance and gait

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  2. Falls efficacy

    measured by the Chinese version of the Falls Efficacy Scale International; min: 16; max: 64; higher scores reflect greater concern about falling

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  3. Conscious movement processing

    measured by the Chinese version of the Movement Specific Reinvestment Scale; min: 10, max: 60; higher scores reflect higher propensity for conscious movement processing

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  4. Functional balance

    measured by the Berg Balance Scale; min: 0; max: 56; higher scores reflect better functional balance

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

  5. Functional mobility

    measured by the Timed 'Up \& Go' Test (in seconds); a longer time to complete reflects poorer functional mobility

    Measured: baseline (pre-intervention), immediately after intervention (post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start1 Aug 2025 (estimated)
  3. Primary completionFeb 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07085364
Sponsor's protocol ID
HSEARS20250107004
Status last verified
Jun 2025
First submitted
5 Jun 2025
Last updated
25 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Attentional focus in people with Gait and Attention, run by The Hong Kong Polytechnic University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait stability - variability of stride time (time frame: baseline (pre-intervention), immediately after intervention (post-intervention)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in